Literature DB >> 20039155

Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy.

D L Pountney1, T C Dickson, J H T Power, J C Vickers, A J West, W P Gai.   

Abstract

Multiple system atrophy (MSA) is an adult-onset neurodegenerative disease characterised by Parkinsonian and autonomic symptoms and by widespread intracytoplasmic inclusion bodies in oligodendrocytes. These glial cytoplasmic inclusions (GCIs) are comprised of 9-10 nm filaments rich in the protein alpha-synuclein, also found in neuronal inclusion bodies associated with Parkinson's disease. Metallothioneins (MTs) are a class of low-molecular weight (6-7 kDa), cysteine-rich metal-binding proteins the expression of which is induced by heavy metals, glucocorticoids, cytokines and oxidative stress. Recent studies have shown a role for the ubiquitously expressed MT-I/II isoforms in the brain following a variety of stresses, whereas, the function of the brain-specific MT isoform, MT-III, is less clear. MT-III and MT-I/II immunostaining of post-mortem tissue in MSA and normal control human brains showed that the number of MT-III-positive cells is significantly increased in MSA in visual cortex, whereas MT-I/II isoforms showed no significant difference in the distribution of immunopositive cells in MSA compared to normal tissue. GCIs were immunopositive for MT-III, but were immunonegative for the MT-I/II isoforms. Immunofluorescence double labelling showed the co-localisation of alpha-synuclein and MT-III in GCIs in MSA tissue. In isolated GCIs, transmission electron microscopy demonstrated MT-III immunogold labelling of the amorphous material surrounding alpha-synuclein filaments in GCIs. High-molecular weight MT-III species in addition to MT-III monomer were detected in GCIs by Western analysis of the detergent-solubilised proteins of purified GCIs. These results show that MT-III, but not MT-I/II, is a specific component of GCIs, present in abnormal aggregated forms external to the alpha-synuclein filaments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20039155     DOI: 10.1007/s12640-009-9146-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  36 in total

1.  Metallothionein-III knockout mice aggravates the neuronal damage after transient focal cerebral ischemia.

Authors:  Akihiro Koumura; Junya Hamanaka; Masamitsu Shimazawa; Akiko Honda; Kazuhiro Tsuruma; Yoko Uchida; Isao Hozumi; Masahiko Satoh; Takashi Inuzuka; Hideaki Hara
Journal:  Brain Res       Date:  2009-07-25       Impact factor: 3.252

2.  Evidence for Cu(I) clusters and Zn(II) clusters in neuronal growth-inhibitory factor isolated from bovine brain.

Authors:  R Bogumil; P Faller; D L Pountney; M Vasák
Journal:  Eur J Biochem       Date:  1996-06-15

3.  alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy.

Authors:  W P Gai; D L Pountney; J H T Power; Q X Li; J G Culvenor; C A McLean; P H Jensen; P C Blumbergs
Journal:  Exp Neurol       Date:  2003-05       Impact factor: 5.330

4.  Metallothionein-III induces HIF-1alpha-mediated VEGF expression in brain endothelial cells.

Authors:  Hyung Gyun Kim; Yong Pil Hwang; Hye Gwang Jeong
Journal:  Biochem Biophys Res Commun       Date:  2008-02-22       Impact factor: 3.575

Review 5.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

6.  Role of metallothionein-III following central nervous system damage.

Authors:  Javier Carrasco; Milena Penkowa; Mercedes Giralt; Jordi Camats; Amalia Molinero; Iain L Campbell; Richard D Palmiter; Juan Hidalgo
Journal:  Neurobiol Dis       Date:  2003-06       Impact factor: 5.996

Review 7.  Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration.

Authors:  Kirk E Dineley; Tatyana V Votyakova; Ian J Reynolds
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

8.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

Review 9.  Multiple system atrophy: a primary oligodendrogliopathy.

Authors:  Gregor K Wenning; Nadia Stefanova; Kurt A Jellinger; Werner Poewe; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  9 in total

1.  Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism.

Authors:  Fleur A McLeary; Alexandre N Rcom-H'cheo-Gauthier; Jessica Kinder; Michael Goulding; Tien K Khoo; George D Mellick; Roger S Chung; Dean L Pountney
Journal:  Neurotox Res       Date:  2017-10-24       Impact factor: 3.911

2.  Metal binding and interdomain thermodynamics of mammalian metallothionein-3: enthalpically favoured Cu+ supplants entropically favoured Zn2+ to form Cu4 + clusters under physiological conditions.

Authors:  Matthew R Mehlenbacher; Rahma Elsiesy; Rabina Lakha; Rhiza Lyne E Villones; Marina Orman; Christina L Vizcarra; Gabriele Meloni; Dean E Wilcox; Rachel N Austin
Journal:  Chem Sci       Date:  2022-04-04       Impact factor: 9.969

3.  SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.

Authors:  Mathew B Wong; Jacob Goodwin; Anwar Norazit; Adrian C B Meedeniya; Christiane Richter-Landsberg; Wei Ping Gai; Dean L Pountney
Journal:  Neurotox Res       Date:  2012-11-15       Impact factor: 3.911

Review 4.  Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Authors:  Benjamin Ettle; Johannes C M Schlachetzki; Jürgen Winkler
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

Review 5.  Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.

Authors:  Yuho Okita; Alexandre N Rcom-H'cheo-Gauthier; Michael Goulding; Roger S Chung; Peter Faller; Dean L Pountney
Journal:  Front Neurosci       Date:  2017-04-04       Impact factor: 4.677

Review 6.  Switching on Endogenous Metal Binding Proteins in Parkinson's Disease.

Authors:  Fleur A McLeary; Alexandre N Rcom-H'cheo-Gauthier; Michael Goulding; Rowan A W Radford; Yuho Okita; Peter Faller; Roger S Chung; Dean L Pountney
Journal:  Cells       Date:  2019-02-19       Impact factor: 6.600

Review 7.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.

Authors:  Seiji Kaji; Takakuni Maki; Tomoyuki Ishimoto; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Transl Neurodegener       Date:  2020-02-17       Impact factor: 8.014

9.  Role of VAPB and vesicular profiles in α-synuclein aggregates in multiple system atrophy.

Authors:  Fumiaki Mori; Yasuo Miki; Kunikazu Tanji; Tomoya Kon; Masahiko Tomiyama; Akiyoshi Kakita; Koichi Wakabayashi
Journal:  Brain Pathol       Date:  2021-07-01       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.